Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu(Stanford Medicine), Fredrik Bäckhed(Sahlgrenska University Hospital), Matteo Sérino(Inserm), Lisa Olsson(Wallenberg Wood Science Center), Rémy Burcelin(Inserm), Gemma Xifra(Universitat de Girona), Rosie Perkins(Wallenberg Wood Science Center), Mercè Planas-Fèlix(Barcelona Supercomputing Center), Valentina Tremaroli(University of Gothenburg), Louise Mannerås-Holm(Wallenberg Wood Science Center), David Torrents(Barcelona Supercomputing Center), José Manuel Fernández‐Real(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Robert Caesar(University of Gothenburg), Josep M. Mercader(Institut d'Investigació Biomédica de Bellvitge), Muhammad Tanweer Khan(Wallenberg Wood Science Center), Eduardo Esteve(Universitat de Girona), Marcus Ståhlman(University of Gothenburg), Wifredo Ricart(Universitat de Girona)
Cited by 1,626
Related Papers
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k